Abstract:Lipid nanoparticles (LNPs) have successfully entered the clinic for the delivery of mRNA- and siRNA-based therapeutics, most recently as vaccines for COVID-19. Nevertheless, there is a lack of understanding regarding their in vivo behavior, in particular cell targeting. Part of this LNP tropism is based on the adherence of endogenous protein to the particle surface. This protein forms a so-called corona that can change, amongst other things, the circulation time, biodistribution and cellular uptake of these particles. The formation of this protein corona, in turn, is dependent on the nanoparticle properties (e.g., size, charge, surface chemistry and hydrophobicity) as well as the biological environment from which it is derived. With the potential of gene therapy to target virtually any disease, administration sites other than intravenous route are considered, resulting in tissue specific protein coronas. For neurological diseases, intracranial administration of LNPs results in a cerebral spinal fluid derived protein corona, possibly changing the properties of the lipid nanoparticle compared to intravenous administration. Here, the differences between plasma and CSF derived protein coronas on a clinically relevant LNP formulation were studied in vitro. Protein analysis showed that LNPs incubated in human CSF (C-LNPs) developed a protein corona composition that differed from that of LNPs incubated in plasma (P-LNPs). Lipoproteins as a whole, but in particular apolipoprotein E, represented a higher percentage of the total protein corona on C-LNPs than on P-LNPs. This resulted in improved cellular uptake of C-LNPs compared to P-LNPs, regardless of cell origin. Importantly, the higher LNP uptake did not directly translate into more efficient cargo delivery, underlining that further assessment of such mechanisms is necessary. These findings show that biofluid specific protein coronas alter LNP functionality, suggesting that the site of administration could affect LNP efficacy in vivo and needs to be considered during the development of the formulation.

Interactions of Apolipoproteins with Lipid-Based Nanoparticles

Nanoparticle charge-transfer interactions induce surface dependent conformational changes in apolipoprotein biocorona

Role of Ligand Conformation on Nanoparticle-Protein Interactions

Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy

Unraveling the impact of different liposomal formulations on the plasma protein corona composition might give hints on the targeting capability of nanoparticles

A comprehensive investigation of the interactions of human serum albumin with polymeric and hybrid nanoparticles

The Effects of Serum Albumin Pre-Adsorption of Nanoparticles on Protein Corona and Membrane Interaction: A Molecular Simulation Study

Nanoparticle protein corona: from structure and function to therapeutic targeting

The protein corona and its effects on nanoparticle-based drug delivery systems

Biofluid specific protein coronas affect lipid nanoparticle behavior in vitro

Protein corona of nanoparticles: distinct proteins regulate the cellular uptake.

Characterization and Biomedical Application Opportunities of the Nanoparticle's Protein Corona

Computational Investigations of the Interaction Between the Cell Membrane and Nanoparticles Coated with a Pulmonary Surfactant.

Computational Insight on the Interaction of Common Blood Proteins with Gold Nanoparticles

Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics

Serum-derived Protein Coronas Affect Nanoparticle Interactions with Brain Cells

Computer Simulation of the Role of Protein Corona in Cellular Delivery of Nanoparticles.

The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery.

Formation of Protein Corona on Nanoparticle Affects Different Complement Activation Pathways Mediated by C1q

Conformational-transited Protein Corona Regulated Cell-Membrane Penetration and Induced Cytotoxicity of Ultrasmall Au Nanoparticles

Phytochemicals as Dynamic Surface Ligands To Control Nanoparticle–Protein Interactions